Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Response to paclitaxel in adenoid cystic carcinoma of the salivary glands.

Till BG, Martins RG.

Head Neck. 2008 Jun;30(6):810-4.

PMID:
17979110
2.

[Chemotherapy with paclitaxel for lung metastases of cystic adenoid carcinoma. A case report and review of the literature].

Perrot E, Davy N, Poubeau P, Arvin-Berod C.

Rev Pneumol Clin. 2003 Dec;59(6):371-4. French.

PMID:
14745344
3.

Metastatic adenoid cystic carcinoma of the salivary gland responding to cetuximab plus weekly paclitaxel after no response to weekly paclitaxel alone.

Caballero M, E Sosa A, Tagliapietra A, Grau JJ.

Head Neck. 2013 Feb;35(2):E52-4. doi: 10.1002/hed.21870. Epub 2011 Dec 5.

PMID:
22144378
4.

[Docetaxel in the treatment of metastatic carcinoma of the salivary glands: report of a case].

Belli F, Di Lauro L, Zappanico A, Giunta S.

Clin Ter. 1999 Jan-Feb;150(1):77-9. Italian.

PMID:
10367547
5.

Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group.

Gilbert J, Li Y, Pinto HA, Jennings T, Kies MS, Silverman P, Forastiere AA.

Head Neck. 2006 Mar;28(3):197-204.

PMID:
16470745
6.

Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.

Wong SJ, Karrison T, Hayes DN, Kies MS, Cullen KJ, Tanvetyanon T, Argiris A, Takebe N, Lim D, Saba NF, Worden FP, Gilbert J, Lenz HJ, Razak AR, Roberts JD, Vokes EE, Cohen EE.

Ann Oncol. 2016 Feb;27(2):318-23. doi: 10.1093/annonc/mdv537. Epub 2015 Nov 23.

7.

Tamoxifen for salivary gland adenoid cystic carcinoma: report of two cases.

Elkin AD, Jacobs CD.

J Cancer Res Clin Oncol. 2008 Oct;134(10):1151-3. doi: 10.1007/s00432-008-0377-3. Epub 2008 Mar 18.

PMID:
18347813
8.

Bilateral intraosseous adenoid cystic carcinoma of the mandible: report of a case with lung metastases at first clinical presentation.

Capodiferro S, Scully C, Macaita MG, Lo Muzio L, Favia G, Mairoano E.

Oral Dis. 2005 Mar;11(2):109-12. Erratum in: Oral Dis. 2005 May;11(3):195. Lacaita, MG [corrected to Macaita, MG; Favic, G [corrected to Favia, G].

PMID:
15752085
9.

Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma.

Ghosal N, Mais K, Shenjere P, Julyan P, Hastings D, Ward T, Ryder WD, Bruce I, Homer J, Slevin NJ.

Br J Oral Maxillofac Surg. 2011 Oct;49(7):510-5. doi: 10.1016/j.bjoms.2010.09.013. Epub 2010 Nov 10.

PMID:
21071117
10.

Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands.

Agulnik M, Cohen EW, Cohen RB, Chen EX, Vokes EE, Hotte SJ, Winquist E, Laurie S, Hayes DN, Dancey JE, Brown S, Pond GR, Lorimer I, Daneshmand M, Ho J, Tsao MS, Siu LL.

J Clin Oncol. 2007 Sep 1;25(25):3978-84.

PMID:
17761983
11.

Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).

Kim Y, Lee SJ, Lee JY, Lee SH, Sun JM, Park K, An HJ, Cho JY, Kang EJ, Lee HY, Kim J, Keam B, Kim HR, Lee KE, Choi MY, Lee KH, Ahn MJ.

Cancer. 2017 Jun 1;123(11):1958-1964. doi: 10.1002/cncr.30537. Epub 2017 Jan 19.

PMID:
28102887
12.

A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC.

Chau NG, Hotte SJ, Chen EX, Chin SF, Turner S, Wang L, Siu LL.

Ann Oncol. 2012 Jun;23(6):1562-70. doi: 10.1093/annonc/mdr522. Epub 2011 Nov 11.

PMID:
22080184
13.

Intra-arterial cisplatin treatment of adenoid cystic carcinoma.

Sessions RB, Lehane DE, Smith RJ, Bryan RN, Suen JY.

Arch Otolaryngol. 1982 Apr;108(4):221-4.

PMID:
6280657
14.

[Antimetastatic effects of genistein on salivary adenoid cystic carcinoma in vivo].

Liu H, Yu GY.

Zhonghua Kou Qiang Yi Xue Za Zhi. 2004 Sep;39(5):373-5. Chinese.

PMID:
15498340
15.

Inhibition of autophagy enhances cisplatin cytotoxicity in human adenoid cystic carcinoma cells of salivary glands.

Ma B, Liang LZ, Liao GQ, Liang YJ, Liu HC, Zheng GS, Su YX.

J Oral Pathol Med. 2013 Nov;42(10):774-80. doi: 10.1111/jop.12066. Epub 2013 Apr 17.

PMID:
23590333
16.

Sulforaphane induces G2-M arrest and apoptosis in high metastasis cell line of salivary gland adenoid cystic carcinoma.

Chu WF, Wu DM, Liu W, Wu LJ, Li DZ, Xu DY, Wang XF.

Oral Oncol. 2009 Nov;45(11):998-1004. doi: 10.1016/j.oraloncology.2009.05.641. Epub 2009 Jul 8.

PMID:
19589718
17.

Distant metastases of adenoid cystic carcinoma of the salivary glands and the value of diagnostic examinations during follow-up.

van der Wal JE, Becking AG, Snow GB, van der Waal I.

Head Neck. 2002 Aug;24(8):779-83.

PMID:
12203804
18.

Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review.

Laurie SA, Ho AL, Fury MG, Sherman E, Pfister DG.

Lancet Oncol. 2011 Aug;12(8):815-24. doi: 10.1016/S1470-2045(10)70245-X. Epub 2010 Dec 10. Review.

PMID:
21147032
19.

Lung metastasis resection of adenoid cystic carcinoma of salivary glands.

Bobbio A, Copelli C, Ampollini L, Bianchi B, Carbognani P, Bettati S, Sesenna E, Rusca M.

Eur J Cardiothorac Surg. 2008 May;33(5):790-3. doi: 10.1016/j.ejcts.2007.12.057. Epub 2008 Mar 14.

PMID:
18343149
20.

Tumor-doubling time and onset of pulmonary metastasis from adenoid cystic carcinoma of the salivary gland.

Umeda M, Nishimatsu N, Masago H, Ishida Y, Yokoo S, Fujioka M, Shibuya Y, Komori T.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Oct;88(4):473-8.

PMID:
10519758

Supplemental Content

Support Center